This paper reviews a novel insulin analogue, degludec, which has the potential to emerge as an ideal basal insulin. It reviews the limitations of existing basal insulin and analogues, and highlights the need for a newer molecule. The paper discusses the potential advantages of degludec, while reviewing its pharmacologic and clinical studies done so far. The paper assesses the potential role of insulin degludec and degludec plus in clinical diabetes practice.
CITATION STYLE
Kalra, S., Unnikrishnan, A., Baruah, M., & Kalra, B. (2011). Degludec insulin: A novel basal insulin. Indian Journal of Endocrinology and Metabolism, 15(5), 12. https://doi.org/10.4103/2230-8210.83056
Mendeley helps you to discover research relevant for your work.